California State Teachers Retirement System (CalSTRS)
ESPR

California State Teachers Retirement System (CalSTRS)’s Esperion Therapeutics ESPR Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$35.8K Sell
13,076
-1,330
-9% -$4.21K ﹤0.01% 2282
2025
Q4 		$53.3K Buy
14,406
+1,971
+16% +$6.37K ﹤0.01% 2295
2025
Q3 		$33K Sell
12,435
-1,257
-9% -$2.43K ﹤0.01% 2380
2025
Q2 		$13.5K Hold
13,692
– – ﹤0.01% 2629
2025
Q1 		$19.7K Hold
13,692
– – ﹤0.01% 2525
2024
Q4 		$30.1K Hold
13,692
– – ﹤0.01% 2484
2024
Q3 		$22.6K Hold
13,692
– – ﹤0.01% 2561
2024
Q2 		$30.4K Buy
+13,692
New +$32.2K ﹤0.01% 2477
2023
Q2 		– Sell
-97,511
Closed -$155K – 3140
2023
Q1 		$155K Buy
97,511
+18,943
+24% +$97.8K ﹤0.01% 2617
2022
Q4 		$489K Buy
78,568
+52,275
+199% +$374K ﹤0.01% 2344
2022
Q3 		$176K Sell
26,293
-675
-3% -$4.64K ﹤0.01% 2662
2022
Q2 		$172K Buy
26,968
+2,224
+9% +$12.6K ﹤0.01% 2708
2022
Q1 		$115K Buy
24,744
+10,589
+75% +$45.4K ﹤0.01% 2822
2021
Q4 		$71K Sell
14,155
-20,205
-59% -$162K ﹤0.01% 3087
2021
Q3 		$414K Sell
34,360
-1,828
-5% -$26.6K ﹤0.01% 2516
2021
Q2 		$765K Sell
36,188
-2,851
-7% -$68.7K ﹤0.01% 2388
2021
Q1 		$1.09M Sell
39,039
-151
-0.4% -$4.46K ﹤0.01% 2093
2020
Q4 		$1.02M Hold
39,190
– – ﹤0.01% 2022
2020
Q3 		$1.46M Buy
39,190
+156
+0.4% +$6.18K ﹤0.01% 1675
2020
Q2 		$2M Buy
39,034
+801
+2% +$33.5K ﹤0.01% 1474
2020
Q1 		$1.21M Sell
38,233
-431
-1% -$22.7K ﹤0.01% 1584
2019
Q4 		$2.31M Sell
38,664
-190
-0.5% -$8.54K ﹤0.01% 1482
2019
Q3 		$1.42M Buy
38,854
+464
+1% +$18.4K ﹤0.01% 1730
2019
Q2 		$1.79M Buy
38,390
+3,100
+9% +$146K ﹤0.01% 1628
2019
Q1 		$1.42M Sell
35,290
-556
-2% -$24.9K ﹤0.01% 1742
2018
Q4 		$1.65M Buy
35,846
+747
+2% +$36K ﹤0.01% 1597
2018
Q3 		$1.56M Buy
35,099
+81
+0.2% +$3.72K ﹤0.01% 1795
2018
Q2 		$1.37M Buy
35,018
+8,666
+33% +$438K ﹤0.01% 1856
2018
Q1 		$1.91M Sell
26,352
-395
-1% -$29K ﹤0.01% 1560
2017
Q4 		$1.76M Sell
26,747
-407
-1% -$21.9K ﹤0.01% 1650
2017
Q3 		$1.36M Buy
27,154
+738
+3% +$35.6K ﹤0.01% 1824
2017
Q2 		$1.22M Sell
26,416
-1,800
-6% -$66.2K ﹤0.01% 1923
2017
Q1 		$996K Sell
28,216
-1,200
-4% -$27.5K ﹤0.01% 2081
2016
Q4 		$368K Sell
29,416
-900
-3% -$10.7K ﹤0.01% 2673
2016
Q3 		$420K Buy
30,316
+300
+1% +$3.4K ﹤0.01% 2592
2016
Q2 		$297K Buy
30,016
+2,251
+8% +$37.3K ﹤0.01% 2764
2016
Q1 		$470K Buy
27,765
+3,415
+14% +$54.9K ﹤0.01% 2461
2015
Q4 		$542K Buy
24,350
+386
+2% +$9.74K ﹤0.01% 2377
2015
Q3 		$565K Hold
23,964
– – ﹤0.01% 2345
2015
Q2 		$1.96M Buy
23,964
+11,767
+96% +$1.15M ﹤0.01% 1667
2015
Q1 		$1.13M Buy
12,197
+800
+7% +$51.6K ﹤0.01% 1951
2014
Q4 		$461K Buy
11,397
+2,848
+33% +$87.2K ﹤0.01% 2532
2014
Q3 		$209K Buy
8,549
+49
+0.6% +$779 ﹤0.01% 2892
2014
Q2 		$135K Buy
8,500
+300
+4% +$4.33K ﹤0.01% 2979
2014
Q1 		$124K Hold
8,200
– – ﹤0.01% 2975
2013
Q4 		$113K Buy
8,200
+1,600
+24% +$23.3K ﹤0.01% 2977
2013
Q3 		$124K Buy
+6,600
New +$111K ﹤0.01% 2952

Other funds holding ESPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s ESPR Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Esperion Therapeutics (ESPR) stake by 9.2% in Q1 2026, selling an estimated $4.21K and leaving 13,076 shares worth $35.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2282.

California State Teachers Retirement System (CalSTRS) first reported a position in ESPR in Q3 2013 and has held it in 47 quarters since. The position peaked at $2.31M in Q4 2019. 205 funds tracked by Wall St. Rank hold ESPR as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) held 13,076 shares of Esperion Therapeutics worth $35.8K as of Q1 2026.
  • California State Teachers Retirement System (CalSTRS) sold 1,330 Esperion Therapeutics shares in Q1 2026, an estimated $4.21K.
  • Esperion Therapeutics made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q1 2026, its #2282 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Esperion Therapeutics in Q3 2013 and has held it in 47 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Esperion Therapeutics position peaked at $2.31M in Q4 2019.
  • 205 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.